Oliver Wyman December 1, 2023
Fritz Heese and David Klein

Emerging clinical evidence shows the potential benefits of prescription digital therapeutics. The CEO of Click Therapeutics assesses where the market is heading.

The digital therapeutics market has had its share of ups and downs. While there’s excitement around the potential to bolster patient outcomes, few products have been fully embraced by patients, providers, or insurers. A big stumbling block is the absence of reliable clinical evidence.

But the industry may be at a turning point. The Food and Drug Administration in October announced the creation of a digital health advisory committee charged with offering input on new health technology, including digital therapeutics. Something that may have a more immediate impact is...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, FDA, Govt Agencies, Interview / Q&A, Technology, Trends
Screenagers to Silver Surfers: How each generation clicks with care
Digital Health Rewired 2025: 10 Key Talking Points
New Law Extends Telehealth Flexibilities Another 6 Months
Better Science, Better Medicine: How Clinical Research Advances Women’s Health
Digital Health Adoption Trends by Each Generation: From Gen Z to Boomers

Share This Article